Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women
- PMID: 22448610
- PMCID: PMC3342149
- DOI: 10.1186/1472-6874-12-6
Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women
Abstract
Background: In 2009 the Uterine Bleeding and Pain Women's Research Study (UBP-WRS) was conducted interviewing 21,479 women across 8 countries in order to gain patient-based prevalence data on uterine pain and bleeding indications and investigate uterine symptoms and women's treatment experiences. This article shows relevant results of the study for the indication uterine fibroids providing data on self-reported prevalence, symptomatology and management of uterine fibroids.
Methods: 2,500 women (USA: 4,500 women) in each country (Brazil, Canada, France, Germany, Italy, South Korea, the UK, the USA) completed an online survey. Women included were in their reproductive age (age group 15-49 years; USA: 18-49 years) and had ever experienced menstrual bleedings. Quotas were applied for age, region, level of education and household income of respondents. Variables have been analyzed descriptively and exploratory statistical tests have been performed.
Results: The self-reported prevalence of uterine fibroids ranged from 4.5% (UK) to 9.8% (Italy), reaching 9.4% (UK) to 17.8% (Italy) in the age group of 40-49 years. Women with a diagnosis of uterine fibroids reported significantly more often about bleeding symptoms than women without a diagnosis: heavy bleedings (59.8% vs. 37.4%), prolonged bleedings (37.3% vs. 15.6%), bleeding between periods (33.3% vs. 13.5%), frequent periods (28.4% vs. 15.2%), irregular and predictable periods (36.3% vs. 23.9%). Furthermore women with diagnosed uterine fibroids reported significantly more often about the following pain symptoms: pressure on the bladder (32.6% vs. 15.0%), chronic pelvic pain (14.5% vs. 2.9%), painful sexual intercourse (23.5% vs. 9.1%) and pain occurring mid-cycle, after and during menstrual bleeding (31.3%, 16.7%, 59.7%, vs. 17.1%, 6.4%, 52.0%). 53.7% of women reported that their symptoms had a negative impact on their life in the last 12 month, influencing their sexual life (42.9%), performance at work (27.7%) and relationship & family (27.2%).
Conclusions: Uterine fibroid is a common concern in women at fertile age causing multiple bleeding and pain symptoms which can have a negative impact on different aspects in women's life.
Figures
Similar articles
-
The management of uterine leiomyomas.J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8. J Obstet Gynaecol Can. 2015. PMID: 25767949
-
Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis.Int J Womens Health. 2017 Jun 7;9:403-411. doi: 10.2147/IJWH.S133212. eCollection 2017. Int J Womens Health. 2017. PMID: 28652819 Free PMC article.
-
Uterine fibroids and gynecologic pain symptoms in a population-based study.Fertil Steril. 2003 Dec;80(6):1488-94. doi: 10.1016/s0015-0282(03)02207-6. Fertil Steril. 2003. PMID: 14667888
-
Epidemiology and management of uterine fibroids.Int J Gynaecol Obstet. 2020 Apr;149(1):3-9. doi: 10.1002/ijgo.13102. Epub 2020 Feb 17. Int J Gynaecol Obstet. 2020. PMID: 31960950 Review.
-
Assessing the impact of hormonal contraceptive use on menstrual health among women of reproductive age - a systematic review.Eur J Contracept Reprod Health Care. 2024 Oct;29(5):193-223. doi: 10.1080/13625187.2024.2373143. Epub 2024 Jul 15. Eur J Contracept Reprod Health Care. 2024. PMID: 39007750
Cited by
-
Radiofrequency Volumetric Thermal Ablation of Fibroids and Laparoscopic Myomectomy: Long-Term Follow-up From a Randomized Trial.Geburtshilfe Frauenheilkd. 2015 May;75(5):442-449. doi: 10.1055/s-0035-1545931. Geburtshilfe Frauenheilkd. 2015. PMID: 26097247 Free PMC article.
-
Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix.Int J Mol Med. 2018 Oct;42(4):1857-1864. doi: 10.3892/ijmm.2018.3779. Epub 2018 Jul 17. Int J Mol Med. 2018. PMID: 30015921 Free PMC article.
-
Innovative and conventional "conservative" technologies for the treatment of uterine fibroids in Italy: a multidimensional assessment.Health Econ Rev. 2022 Mar 18;12(1):21. doi: 10.1186/s13561-022-00367-x. Health Econ Rev. 2022. PMID: 35303183 Free PMC article.
-
Endocrine disrupting chemicals and reproductive disorders in women, men, and animal models.Adv Pharmacol. 2021;92:151-190. doi: 10.1016/bs.apha.2021.03.008. Epub 2021 May 3. Adv Pharmacol. 2021. PMID: 34452686 Free PMC article.
-
Metastatic Uterine Leiomyosarcoma as a Rare and Sinister Cause of Respiratory Distress: A Case Report and Literature Review.Cureus. 2023 May 16;15(5):e39101. doi: 10.7759/cureus.39101. eCollection 2023 May. Cureus. 2023. PMID: 37332439 Free PMC article.
References
-
- Rein MS, Barbieri RL, Friedman AJ. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol. 1995;172(1 Pt 1):14–18. - PubMed
-
- Fields KR, Neinstein LS. Uterine myomas in adolescents: case reports and a review of the literature. J Pediatr Adolesc Gynecol. 1996;9(4):195–198. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical